Avatar
Benzinga News source @benzinga.com · Detroit 🇺🇸· Jan 5

#Biopharmaceuticals #LiverDisease #FDAApproval

Link Preview
www.benzinga.com
Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH - Altimmune (NASDAQ:ALT)
GAITHERSBURG, Md.